Novo Going 'All-In' With Wegovy Weight Loss Pill
The US will let Novo Nordisk A/S sell it blockbuster weight loss drug Wegovy in a pill form. Millions of people already take the shot. A trial showed people taking...
By Bloomberg Markets · Bloomberg Markets
The US will let Novo Nordisk A/S sell it blockbuster weight loss drug Wegovy in a pill form. Millions of people already take the shot. A trial showed people taking a 25 milligram pill once daily lost about 13.6% of their body weight over 64 weeks. Novo President and CEO Mike Doustdar speaks to Bloomberg's Katie Greifeld. (Source: Bloomberg)